{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-25-018389","form_type":"8-K","ticker":"XFOR","cik":"0001501697","company_name":"X4 Pharmaceuticals, Inc","filed_at":"2025-04-18T23:59:59+00:00","discovered_at":"2026-05-14T18:02:48.502263+00:00","generated_at":"2026-05-23T10:58:30.176433+00:00","sec_items":["5.07"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"X4 Pharma stockholders approve reverse stock split; ratio 1:15 to 1:30 to be set by board","bullets":["Special meeting held April 17, 2025; ~79% of outstanding shares (137.2M of 173.7M) present, forming quorum.","Reverse split approved: 113.0M FOR, 24.0M AGAINST, 224k abstentions; no broker non-votes.","Amendment authorizes board to set exact ratio between 1-for-15 and 1-for-30.","Related Proposal 2 was not presented because Proposal 1 passed."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-25-018389","json":"https://secwatch.observer/filing/0001628280-25-018389.json","markdown":"https://secwatch.observer/filing/0001628280-25-018389.md","text":"https://secwatch.observer/filing/0001628280-25-018389.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1501697/000162828025018389/0001628280-25-018389-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1501697/000162828025018389/xfor-20250417.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-23T10:58:30.176433+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}